The surgical Navigation Systems Market is poised to witness a CAGR of 6.32% during the forecast period.
The COVID-19 pandemic has significantly impacted the surgical navigation system market, with regional restrictions on elective procedures causing several procedures to be delayed. Moreover, the number of surgeries declined during COVID-19, hampering the market growth. According to a British Journal of Surgery report 2020, approximately 28 million elective surgeries were canceled or postponed during COVID-19. Patients preferred to wait for hospital visits, which impacted the surgical navigation system market. According to the research article 'Impact of Covid-19 on General Surgical Practice in India,' published in June 2020, post-lockdown daily out-patient visits reduced to 4 patients/day in India, and approximately 77% of professionals did not perform even a single surgical procedure. On the other hand, other factors, such as the demand for better patient outcomes and the results of clinical trials, are likely to drive the adoption of new technologies in navigation-assisted surgeries and support long-term market growth.
Surgical navigation systems are an integral part of computer-assisted surgery. This represents a concept that supports surgical procedures based on digital imaging technology. It allows surgeons pre-operative planning and accurate surgical navigation of instruments during the process. The growth is likely to be fueled by the rising prevalence of target conditions such as osteoarthritis, brain tumors, ENT disorders, and the growing senior population. According to the article published in the E-Clinical Medicine 2020, for people aged 15 and up, the prevalence of knee osteoarthritis (OA) was 16%, while in people aged 40 and above, the prevalence was 22.9%. In 2020, roughly 654 million people worldwide (40 years and older) had knee OA. In people aged 20 and above, the global incidence of knee OA was 203 per 10,000 person-years. Surgical navigation systems map the knee of the patient to understand it better and carry out efficient surgical operations. Hence, the demand for this technology is expected to increase.
Other factors like growing demand for minimally invasive procedures and technological advancements are also expected to drive the growth of this market. However, the high cost of surgical navigation systems may restrain some hospitals from adopting them.
Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. The surgical navigation system is becoming more popular in cardiovascular surgery as technology has advanced significantly over the last few years worldwide. Factors such as the increasing occurrence of cardiovascular disorders and the availability of advanced technologies are expected to boost the segment's growth.
According to World Health Organization (WHO) Statistics for June 2021, an estimated 17.9 million people died from cardiovascular diseases in 2019, accounting for 32% of all global deaths. A heart attack or a stroke caused 85% of these deaths. According to the same source, non-communicable diseases were responsible for 17 million premature deaths (under 70) in 2019, with cardiovascular diseases accounting for 38% of these deaths. Hence, cardiac surgery is expected to witness growth due to the increased mortality rate, driving the segment growth.
However, the rise in funding for the treatment of cardiovascular disorders is also expected to boost innovation and research, leading to market growth. According to the National Institutes of Health 2020, the estimated investment for cardiovascular diseases was expected to be USD 2,622 million in 2022. This was a significant increase from the 2021 figures of USD 2,499 million.
The product launches, strategic partnerships, and collaborative agreements are expected to drive the segment over the forecast period. For instance, in November 2020, Abbott received CE Mark and approval in Australia for its new EnSite X EP System and is launching the system throughout Europe and Australia. The EnSite X System is the only system that offers the option to navigate the cardiac anatomy two different ways on one platform.
North America dominates the global surgical navigation systems market, majorly attributed to the well-established healthcare and medical device industry. The market's growth is majorly due to the presence of key companies operating in the surgical navigation systems market.
The increase in the number of surgeries performed in North America is the major driving factor for market growth. For instance, as per the research study published in January 2021, titled "The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania", in 2019, during the pre-COVID time, a total of 3,608 endoscopic procedures were performed, which was about 138 procedures per week. This increases the number of surgeries, rising the demand for a surgical navigation system and driving the market growth.
The geriatric population is more prone to chronic diseases due to the weak immune system. According to World Ageing Report 2019, the United States had 53.340 million people aged 65 years and above in 2019, and this number is expected to reach 84.813 million by 2050. This expected increase in the elderly population is likely to increase the incidence rate of chronic diseases, thus driving the use of surgical navigation systems in diagnosis and treatment.
The Asia-Pacific region is believed to witness the fastest growth over the forecast period, mainly attributed to the increasing adoption of technological advancements in the healthcare industry.
The global key players are developing the majority of the surgical navigation systems. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market grow.
This product will be delivered within 2 business days.
The COVID-19 pandemic has significantly impacted the surgical navigation system market, with regional restrictions on elective procedures causing several procedures to be delayed. Moreover, the number of surgeries declined during COVID-19, hampering the market growth. According to a British Journal of Surgery report 2020, approximately 28 million elective surgeries were canceled or postponed during COVID-19. Patients preferred to wait for hospital visits, which impacted the surgical navigation system market. According to the research article 'Impact of Covid-19 on General Surgical Practice in India,' published in June 2020, post-lockdown daily out-patient visits reduced to 4 patients/day in India, and approximately 77% of professionals did not perform even a single surgical procedure. On the other hand, other factors, such as the demand for better patient outcomes and the results of clinical trials, are likely to drive the adoption of new technologies in navigation-assisted surgeries and support long-term market growth.
Surgical navigation systems are an integral part of computer-assisted surgery. This represents a concept that supports surgical procedures based on digital imaging technology. It allows surgeons pre-operative planning and accurate surgical navigation of instruments during the process. The growth is likely to be fueled by the rising prevalence of target conditions such as osteoarthritis, brain tumors, ENT disorders, and the growing senior population. According to the article published in the E-Clinical Medicine 2020, for people aged 15 and up, the prevalence of knee osteoarthritis (OA) was 16%, while in people aged 40 and above, the prevalence was 22.9%. In 2020, roughly 654 million people worldwide (40 years and older) had knee OA. In people aged 20 and above, the global incidence of knee OA was 203 per 10,000 person-years. Surgical navigation systems map the knee of the patient to understand it better and carry out efficient surgical operations. Hence, the demand for this technology is expected to increase.
Other factors like growing demand for minimally invasive procedures and technological advancements are also expected to drive the growth of this market. However, the high cost of surgical navigation systems may restrain some hospitals from adopting them.
Key Market Trends
Cardiac Surgery Expected to have a Large Market Share
Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. The surgical navigation system is becoming more popular in cardiovascular surgery as technology has advanced significantly over the last few years worldwide. Factors such as the increasing occurrence of cardiovascular disorders and the availability of advanced technologies are expected to boost the segment's growth.
According to World Health Organization (WHO) Statistics for June 2021, an estimated 17.9 million people died from cardiovascular diseases in 2019, accounting for 32% of all global deaths. A heart attack or a stroke caused 85% of these deaths. According to the same source, non-communicable diseases were responsible for 17 million premature deaths (under 70) in 2019, with cardiovascular diseases accounting for 38% of these deaths. Hence, cardiac surgery is expected to witness growth due to the increased mortality rate, driving the segment growth.
However, the rise in funding for the treatment of cardiovascular disorders is also expected to boost innovation and research, leading to market growth. According to the National Institutes of Health 2020, the estimated investment for cardiovascular diseases was expected to be USD 2,622 million in 2022. This was a significant increase from the 2021 figures of USD 2,499 million.
The product launches, strategic partnerships, and collaborative agreements are expected to drive the segment over the forecast period. For instance, in November 2020, Abbott received CE Mark and approval in Australia for its new EnSite X EP System and is launching the system throughout Europe and Australia. The EnSite X System is the only system that offers the option to navigate the cardiac anatomy two different ways on one platform.
North America Expected to Dominate the Surgical Navigation Systems Market
North America dominates the global surgical navigation systems market, majorly attributed to the well-established healthcare and medical device industry. The market's growth is majorly due to the presence of key companies operating in the surgical navigation systems market.
The increase in the number of surgeries performed in North America is the major driving factor for market growth. For instance, as per the research study published in January 2021, titled "The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania", in 2019, during the pre-COVID time, a total of 3,608 endoscopic procedures were performed, which was about 138 procedures per week. This increases the number of surgeries, rising the demand for a surgical navigation system and driving the market growth.
The geriatric population is more prone to chronic diseases due to the weak immune system. According to World Ageing Report 2019, the United States had 53.340 million people aged 65 years and above in 2019, and this number is expected to reach 84.813 million by 2050. This expected increase in the elderly population is likely to increase the incidence rate of chronic diseases, thus driving the use of surgical navigation systems in diagnosis and treatment.
The Asia-Pacific region is believed to witness the fastest growth over the forecast period, mainly attributed to the increasing adoption of technological advancements in the healthcare industry.
Competitive Landscape
The global key players are developing the majority of the surgical navigation systems. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market grow.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Brainlab AG
- B Braun Melsungen AG
- Fiagon AG
- Karl Storz
- Medtronic PLC
- Siemens AG
- Stryker Corporation (Scopis Gmbh)
- Zimmer Biomet Holdings
- Cascination AG
- DePuy Synthes
Methodology
LOADING...
